|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 47, 1994-2003, September 2006 Conjugated linoleic acid and hepatic lipogenesis in mouse: role of the mitochondrial citrate carrier
* Department of Sciences and Biological and Environmental Technologies, University of Lecce, 73100 Lecce, Italy Published, JLR Papers in Press, June 30, 2006.
1 To whom correspondence should be addressed. e-mail: vincenzo.zara{at}unile.it
Conjugated linoleic acid (CLA) is able to reduce adiposity by affecting lipid metabolism. In particular, CLA administration to mice reduces body fat mass with a concomitant lipid accumulation in the liver. We investigated the effects of CLA on the activity of the mitochondrial citrate carrier (CIC), which is implicated in hepatic lipogenesis. The transport activity of the CIC, measured both in intact mitochondria and in the proteoliposomes, progressively increased with the duration of CLA feeding. An increase in the CIC activity of
Supplementary key words tricarboxylate carrier lipogenic enzymes hepatic steatosis Abbreviations: ACC, acetyl-coenzyme A carboxylase; 1,2,3-BTA, 1,2,3-benzenetricarboxylate; CIC, mitochondrial tricarboxylate or citrate carrier; CLA, conjugated linoleic acid; CPT, carnitine palmitoyltransferase
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||